The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A multicenter, randomized controlled phase 2b trial of survivin vaccine SurVaxM plus adjuvant temozolomide for newly diagnosed glioblastoma (SURVIVE).
 
Manmeet Singh Ahluwalia
Stock and Other Ownership Interests - doctible; MedInnovate Advisors LLC; MimiVax; TriSalus Life Sciences
Honoraria - Elsevier; Peerview; Prime Education; Prime Oncology
Consulting or Advisory Role - AlloVir; Anheart Therapeutics; Apollomics; Autem Therapeutics; Bayer; Bugworks; Cairn Therapeutics; Caris Life Sciences; Equillium; GlaxoSmithKline; InSightec; Janssen; Menarini Group; Modifi Bio; NH TherAguix; Nuvation Bio; Prelude Therapeutics; Pyramid Biosciences; SDP Oncology; Siemens Healhineers/Varian Medical Systems; Sumitomo Dainippon Pharma Oncology; ViewRay; Voyager Therapeutics; Xoft
Research Funding - Abbvie (Inst); AstraZeneca (Inst); Bayer (Inst); Boston Biomedical (Inst); Bristol-Myers Squibb (Inst); Incyte (Inst); Merck (Inst); MimiVax (Inst); Novartis (Inst); Novocure (Inst); Pharmacyclics (Inst); Seagen (Inst)
Other Relationship - Idorsia (I); ResMed (I)
 
Michael J Ciesielski
Employment - MimiVax
Leadership - MimiVax
Stock and Other Ownership Interests - MimiVax
Research Funding - MimiVax (Inst)
Patents, Royalties, Other Intellectual Property - Patent holder, SurVaxM
Travel, Accommodations, Expenses - MimiVax
 
David A. Reardon
Stock and Other Ownership Interests - Anheart Therapeutics; Bionaut Labs
Honoraria - Advantagene; Agenus; Anheart Therapeutics; Avita Biomedical, Inc.; Bayer; Blue Rock Therapeutics; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; CeCaVa; Chimeric Therapeutics; Deciphera; DelMar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Genentech/Roche; Imvax; Inovio Pharmaceuticals; Kintara Therapeutics; Kintara Therapeutics; KIYATEC; Medicenna; Merck; Merck KGaA; Monteris Medical; NEUVOGEN; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics; Sumitono Dainippon Pharma; Taiho Pharmaceutical; Taiho Pharmaceutical; Vivacitas Oncology; Y-mAbs Therapeutics
Consulting or Advisory Role - Advantagene; Agenus; Agios; Anheart Therapeutics; Avita Biomedical; Bayer; Blue Rock Therapeutics; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; CeCava; Chimeric Therapeutics; Deciphera; Delmar Pharmaceuticals; Ellipses Pharma; EMD Serono; Genenta Science; Genentech/Roche; Imvax; Inovio Pharmaceuticals; Kintara Therapeutics; Kiyatec; Medicenna; Merck; Merck KGaA; NEUVOGEN; Novartis; Novocure; Oncorus; Oxigene; Regeneron; Stemline Therapeutics; Sumitomo Dainippon Pharma Oncology; Taiho Pharmaceutical; Vivacitas Oncology
Research Funding - Acerta Pharma (Inst); Agenus (Inst); Asvattha Therapeutics (Inst); Celldex (Inst); EMD Serono (Inst); Enterome (Inst); Incyte (Inst); Inovio Pharmaceuticals (Inst); InSightec (Inst); Merck (Inst); NeoTX (Inst); Novartis (Inst); Omniox
 
Nicholas A. Butowski
Employment - University of California, San Francisco
Stock and Other Ownership Interests - Cordance; Cordance
Consulting or Advisory Role - IN8Bio; Ipsen; KIYATEC; Novartis; Plus Therapeutics; VBI Vaccines
Research Funding - Abbvie (Inst); Amgen; Amgen (Inst); Arbor Pharmaceuticals (Inst); BeiGene (Inst); BeiGene (Inst); BioMimetix (Inst); Bristol-Myers Squibb (Inst); Deciphera (Inst); EpicentRx; Five Prime Therapeutics; Ipsen; Istari (Inst); KIYATEC (Inst); Medicenna; Merck; Oncoceutics (Inst); Orbus Therapeutics; Tocagen (Inst)
 
Robert Aiken
Stock and Other Ownership Interests - Johnson & Johnson/Janssen; Northwest Biotherapeutics
Consulting or Advisory Role - tactical
Research Funding - Abbott/AbbVie; Avila Therapeutics; Oncoceutics (Inst)
Expert Testimony - Tactical Therapeutics
Other Relationship - Imvax
 
Vyshak Venur
Honoraria - Elsevier
Consulting or Advisory Role - Seagen
 
Ajay Prakash Abad
No Relationships to Disclose
 
Laszlo Mechtler
Leadership - Dent Neurologic Institute, Roswell Park Cancer Institute, SUNY Buffalo
Honoraria - Amgen, Allergan, Currax, Lundbeck
Consulting or Advisory Role - Allergan, Amgen, AbbVie, Lundbeck, Teva
Speakers' Bureau - Amgen, Allergan, AbbVie, Biohaven Pharmaceuticals, Teva
Research Funding - Allergan (Inst), Amgen (Inst), AbbVie (Inst), Aeon, BioPharma (Inst), Alder Biopharmaceuticals (Inst), Biohaven Pharmaceuticals (Inst), Boston Biomedical (Inst), Charlotte’s Web (Inst), DelMar Pharmaceuticals (Inst), Lundbeck (Inst), Novartis (Inst), Orbi
Travel, Accommodations, Expenses - Allergan
 
David M. Peereboom
Honoraria - Novocure
Consulting or Advisory Role - Anheart Therapeutics; Neonc Technologies; Novocure; Orbus Therapeutics; SERVIER; Stemline Therapeutics
Research Funding - Apollomics (Inst); Bayer (Inst); Bristol-Myers Squibb (Inst); Genentech/Roche (Inst); Global Coalition for Adaptive Research (Inst); Karyopharm Therapeutics (Inst); MimiVax (Inst); Neonc Technologies (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Orbus Therapeutics (Inst); Pfizer (Inst); Pharmacyclics (Inst); Vigeo Therapeutics (Inst)
Travel, Accommodations, Expenses - Novocure
Other Relationship - IN8bio (Inst)
 
Yazmin Odia
Consulting or Advisory Role - GammaTile; Istari; PharPoint Research
Research Funding - Bristol-Myers Squibb (Inst); Novocure (Inst)
(OPTIONAL) Uncompensated Relationships - Actuate Therapeutics; Chimerix
 
Kaylyn Sinicrope
No Relationships to Disclose
 
John A Boockvar
No Relationships to Disclose
 
Andrew J. Brenner
Leadership - NanoTX
Stock and Other Ownership Interests - NanoTX; Plus Therapeutics
Honoraria - Seagen; Vascular Biogenics
Consulting or Advisory Role - Alamab Therapeutics; NanoTX; Plus Therapeutics; Vascular Biogenics
Research Funding - Gilead Sciences (Inst); Immunomedics (Inst); Plus Therapeutics (Inst); Upsher-Smith (Inst)
Patents, Royalties, Other Intellectual Property - I have intellectual property interest in NanoTx Therapeutics
Travel, Accommodations, Expenses - Vascular Biogenics
 
Marissa Barbaro
No Relationships to Disclose
 
Ahmad Ozair
No Relationships to Disclose
 
Ahmed Belal
No Relationships to Disclose
 
Jing-Xin Qiu
No Relationships to Disclose
 
Atulya Aman Khosla
No Relationships to Disclose
 
Danielle M. Casucci
Employment - MimiVax
 
Robert Alan Fenstermaker
Stock and Other Ownership Interests - MimiVax
Patents, Royalties, Other Intellectual Property - Patent holder, SurVaxM